Davis Rea Ltd. Danaher Corp Transaction History

Davis Rea Ltd.

$229 Million
Q3 2024

A detailed history of Davis Rea Ltd. transactions in Danaher Corp stock. As of the latest transaction made, Davis Rea Ltd. holds 16,167 shares of DHR stock, worth $3.69 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares

16,167

Previous 16,369 1.23%

Holding current value

$3.69 Million

Previous $4.09 Million 9.9%

% of portfolio

1.96%

Previous 2.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$239.25 - $280.76 $48,328 - $56,713	-202 Reduced 1.23%	16,167 $4.49 Million
Q2 2024 Jul 25, 2024	SELL	$235.51 - $267.98 $1.45 Million - $1.65 Million	-6,167 Reduced 27.37%	16,369 $4.09 Million
Q1 2024 May 06, 2024	SELL	$224.58 - $256.19 $162,820 - $185,737	-725 Reduced 3.12%	22,536 $5.63 Million
Q4 2023 Jan 24, 2024	SELL	$185.1 - $233.13 $563,999 - $710,347	-3,047 Reduced 11.58%	23,261 $5.38 Million
Q3 2023 Oct 19, 2023	SELL	$233.08 - $265.59 $30,067 - $34,261	-129 Reduced 0.49%	26,308 $6.53 Million
Q2 2023 Jul 13, 2023	SELL	$224.99 - $256.14 $183,816 - $209,266	-817 Reduced 3.0%	26,437 $6.34 Million
Q1 2023 Apr 20, 2023	SELL	$239.75 - $277.0 $232,078 - $268,136	-968 Reduced 3.43%	27,254 $6.87 Million
Q4 2022 Jan 24, 2023	SELL	$241.42 - $282.29 $171,166 - $200,143	-709 Reduced 2.45%	28,222 $7.5 Million
Q3 2022 Oct 21, 2022	SELL	$247.06 - $1507.4 $7.53 Million - $46 Million	-30,493 Reduced 51.31%	28,931 $7.48 Million
Q2 2022 Jul 21, 2022	BUY	$237.11 - $299.66 $7.27 Million - $9.19 Million	30,658 Added 106.58%	59,424 $15.1 Million
Q1 2022 Apr 25, 2022	SELL	$257.27 - $315.76 $711,866 - $873,707	-2,767 Reduced 8.77%	28,766 $1.54 Million
Q4 2021 Jan 25, 2022	SELL	$292.08 - $329.01 $354,293 - $399,089	-1,213 Reduced 3.7%	31,533 $10.4 Million
Q3 2021 Oct 25, 2021	SELL	$272.21 - $332.43 $90,373 - $110,366	-332 Reduced 1.0%	32,746 $9.98 Million
Q2 2021 Jul 14, 2021	SELL	$225.08 - $271.69 $384,211 - $463,774	-1,707 Reduced 4.91%	33,078 $8.88 Million
Q1 2021 May 03, 2021	SELL	$212.38 - $245.9 $152,913 - $177,048	-720 Reduced 2.03%	34,785 $7.84 Million
Q4 2020 Jan 15, 2021	SELL	$212.5 - $245.46 $84,575 - $97,693	-398 Reduced 1.11%	35,505 $7.89 Million
Q3 2020 Nov 04, 2020	SELL	$177.16 - $215.33 $13,818 - $16,795	-78 Reduced 0.22%	35,903 $7.74 Million
Q2 2020 Jul 20, 2020	SELL	$128.7 - $176.83 $10,810 - $14,853	-84 Reduced 0.23%	35,981 $6.37 Million
Q1 2020 Apr 30, 2020	SELL	$121.39 - $169.05 $106,823 - $148,764	-880 Reduced 2.38%	36,065 $5 Million
Q4 2019 Jan 27, 2020	SELL	$133.47 - $153.48 $589,536 - $677,921	-4,417 Reduced 10.68%	36,945 $5.68 Million
Q3 2019 Oct 29, 2019	SELL	$135.4 - $146.47 $2.56 Million - $2.77 Million	-18,900 Reduced 31.36%	41,362 $5.98 Million
Q2 2019 Jul 08, 2019	SELL	$124.88 - $143.73 $133,746 - $153,934	-1,071 Reduced 1.75%	60,262 $8.62 Million
Q1 2019 Apr 11, 2019	SELL	$97.62 - $132.29 $18,547 - $25,135	-190 Reduced 0.31%	61,333 $8.11 Million
Q4 2018 Jan 22, 2019	SELL	$94.85 - $109.54 $118,847 - $137,253	-1,253 Reduced 2.0%	61,523 $6.36 Million
Q3 2018 Oct 23, 2018	SELL	$98.13 - $108.9 $225,208 - $249,925	-2,295 Reduced 3.53%	62,776 $6.83 Million
Q2 2018 Aug 03, 2018	SELL	$96.1 - $103.24 $236,694 - $254,280	-2,463 Reduced 3.65%	65,071 $6.43 Million
Q1 2018 Apr 06, 2018	SELL	$92.16 - $103.8 $138,516 - $156,011	-1,503 Reduced 2.18%	67,534 $6.62 Million
Q4 2017 Feb 08, 2018	SELL	$85.26 - $94.62 $47,404 - $52,608	-556 Reduced 0.8%	69,037 $6.42 Million
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $5.52 Million - $6.16 Million	69,593	69,593 $5.98 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $166B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Rea Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davis Rea Ltd. with notifications on news.

Account